Search results for "Highlights"
PPIs not associated with mortality risk for most causes, study finds
While patients who took proton-pump inhibitors (PPIs) had significantly higher risks of all-cause mortality and mortality due to cancer, cardiovascular diseases, respiratory diseases, and digestive diseases, lag times of up to six years attenuated these associations so they were no longer statistically significant.
https://gastroenterology.acponline.org/archives/2022/07/22/1.htm
22 Jul 2022
Transportation, patient education among factors affecting colonoscopy rates after abnormal FIT, survey finds
Primary care physicians and staff were asked to identify patients' barriers to completing colonoscopy after an abnormal fecal immunochemical test (FIT) result, as well as factors that made completion more likely.
https://gastroenterology.acponline.org/archives/2021/08/27/2.htm
27 Aug 2021
Mailed FIT screening for CRC effective, cost-effective in safety-net population
Patients at a federally qualified health center system in Central Texas who were not up to date on colorectal cancer (CRC) screening were mailed a packet containing an introductory letter, a fecal immunochemical test (FIT), easy-to-read instructions, and a postage-paid lab mailer.
https://gastroenterology.acponline.org/archives/2021/05/28/2.htm
28 May 2021
Education for patients reduced upper GI endoscopies for uninvestigated dyspepsia
To reduce overuse, a Dutch trial provided a self-managed, web-based educational intervention containing information on gastric function, dyspepsia, and upper GI tract endoscopy to some patients referred for the procedure by their primary care clinicians.
https://gastroenterology.acponline.org/archives/2021/05/28/3.htm
28 May 2021
Half of overweight, obese adults may have fatty liver disease
The global prevalence of metabolic dysfunction-associated fatty liver disease, a newly proposed term for nonalcoholic fatty liver disease, is “astonishingly high,” the authors of a recent meta-analysis found.
https://gastroenterology.acponline.org/archives/2021/02/26/3.htm
26 Feb 2021
Antibody-based multitarget FIT may be more accurate than standard FIT
A multitarget fecal immunochemical test (FIT) could reduce colorectal cancer incidence and death and might be cost-effective, according to a recent validation study.
https://gastroenterology.acponline.org/archives/2021/07/23/3.htm
23 Jul 2021
Spotlight on PPIs and cancer
Recent studies assessed the association between proton-pump inhibitors (PPIs) and cancer, as well as the effects of PPI treatment after a cancer diagnosis.
https://gastroenterology.acponline.org/archives/2021/07/23/5.htm
23 Jul 2021
GI symptoms associated with better outcomes from COVID-19, new two-part study finds
SARS-CoV-2 was commonly present in the gastrointestinal tract but didn't cause inflammation there, according to a recent analysis of intestinal biopsy tissues from patients with COVID-19.
https://gastroenterology.acponline.org/archives/2021/03/26/2.htm
26 Mar 2021
Use of PPIs may be associated with C. difficile infections
A Danish nationwide cohort study found that ongoing exposure to proton-pump inhibitors (PPIs) was associated with moderately increased community-associated Clostridioides difficile infection risk during treatment and for up to one year afterward.
https://gastroenterology.acponline.org/archives/2021/03/26/3.htm
26 Mar 2021
Failure to undergo colonoscopy after positive FIT may double risk for death from colorectal cancer
A retrospective cohort study in Italy compared 10-year cumulative incidence and mortality among patients with a positive result on a fecal immunochemical test (FIT) who completed a diagnostic colonoscopy versus those who did not.
https://gastroenterology.acponline.org/archives/2021/04/23/3.htm
23 Apr 2021